CeO2 Nanoparticles-assisted stem-based cell therapy: an innovative nanopharmaceutical approach to treat retinal degenerative diseases.
Description: The main objective of CELLUX is to develop a novel pharmaceutical-based CeO2 eye drops to treat AMD (Age-related Macular Degeneration) that in combination with stem cell-based therapeutic strategies, will not only stop degeneration but restore vision.
Amount: CZK 2,348,000
Funding type: research
Funder scheme: TH - EPSILON
Start date: 2020-01-01
End date: 2022-12-31
Investigators: Alena Ševců, Alena Ševců, Alena Ševců, Alena Ševců, Huynh Anh Nhung Nguyen, Miroslava Rysová, Huynh Anh Nhung Nguyen, Miroslava Rysová
Institution: Technická univerzita v Liberci / Rektorát
Funded outputs count: 0
Funder award ID: TH70020001
OpenAlex ID: G9000593192